Mirae Asset Global Etfs Holdings Ltd. Veracyte, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Veracyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 192,151 shares of VCYT stock, worth $7.77 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
192,151
Previous 209,146
8.13%
Holding current value
$7.77 Million
Previous $7.12 Million
6.91%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
336Shares Held
80.2MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$332 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$315 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$267 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$170 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$165 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.89B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...